Literature DB >> 31842008

Dosimetric impact of soft-tissue based intrafraction motion from 3D cine-MR in prostate SBRT.

D M de Muinck Keizer1, C Kontaxis, L G W Kerkmeijer, J R N van der Voort van Zyp, C A T van den Berg, B W Raaymakers, J J W Lagendijk, J C J de Boer.   

Abstract

To investigate the dosimetric impact of intrafraction translation and rotation motion of the prostate, as extracted from daily acquired post-treatment 3D cine-MR based on soft-tissue contrast, in extremely hypofractionated (SBRT) prostate patients. Accurate dose reconstruction is performed by using a prostate intrafraction motion trace which is obtained with a soft-tissue based rigid registration method on 3D cine-MR dynamics with a temporal resolution of 11 s. The recorded motion of each time-point was applied to the planning CT, resulting in the respective dynamic volume used for dose calculation. For each treatment fraction, the treatment delivery record was generated by proportionally splitting the plan into 11 s intervals based on the delivered monitor units. For each fraction the doses of all partial plan/dynamic volume combinations were calculated and were summed to lead to the motion-affected fraction dose. Finally, for each patient the five fraction doses were summed, yielding the total treatment dose. Both daily and total doses were compared to the original reference dose of the respective patient to assess the impact of the intrafraction motion. Depending on the underlying motion of the prostate, different types of motion-affected dose distributions were observed. The planning target volumes (PTVs) ensured CTV_30 (seminal vesicles) D99% coverage for all patients, CTV_35 (prostate corpus) coverage for 97% of the patients and GTV_50 (local boost) for 83% of the patients when compared against the strict planning target D99% value. The dosimetric impact due to prostate intrafraction motion in extremely hypofractionated treatments was determined. The presented study is an essential step towards establishing the actual delivered dose to the patient during radiotherapy fractions.

Entities:  

Year:  2020        PMID: 31842008     DOI: 10.1088/1361-6560/ab6241

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  4 in total

1.  Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system.

Authors:  Charis Kontaxis; Daan M de Muinck Keizer; Linda G W Kerkmeijer; Thomas Willigenburg; Mariska D den Hartogh; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Jochem Hes; Bas W Raaymakers; Jan J W Lagendijk; Hans C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2020-07-13

2.  On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy.

Authors:  Daan M de Muinck Keizer; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Bas W Raaymakers; Jan J W Lagendijk; Hans C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-25

3.  Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer.

Authors:  Christoph Oehler; Nina Roehner; Marcin Sumila; Jürgen Curschmann; Fabrizio Storelli; Daniel Rudolf Zwahlen; Uwe Schneider
Journal:  Curr Oncol       Date:  2022-08-31       Impact factor: 3.109

4.  Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.

Authors:  Francesco Cuccia; Rosario Mazzola; Luca Nicosia; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Claudio Vitale; Beatrice Mantoan; Antonio De Simone; Gianluisa Sicignano; Ruggero Ruggieri; Stefano Cavalleri; Filippo Alongi
Journal:  Radiat Oncol       Date:  2020-07-22       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.